Cationic rifampicin nanoemulsion for the treatment of ocular tuberculosis (2020)
Fonte: Colloids and Surfaces A: Physicochemical and Engineering Aspects. Unidade: FCF
Assuntos: TUBERCULOSE, QUITOSANA, NANOTECNOLOGIA
ABNT
HENOSTROZA, Mirla Anali Bazán et al. Cationic rifampicin nanoemulsion for the treatment of ocular tuberculosis. Colloids and Surfaces A: Physicochemical and Engineering Aspects, v. 597, p. 1-11 art. 124755, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.colsurfa.2020.124755. Acesso em: 01 nov. 2024.APA
Henostroza, M. A. B., Melo, K. J. C., Yukuyama, M. N., Löbenberg, R., & Bou-Chacra, N. A. (2020). Cationic rifampicin nanoemulsion for the treatment of ocular tuberculosis. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 597, 1-11 art. 124755. doi:10.1016/j.colsurfa.2020.124755NLM
Henostroza MAB, Melo KJC, Yukuyama MN, Löbenberg R, Bou-Chacra NA. Cationic rifampicin nanoemulsion for the treatment of ocular tuberculosis [Internet]. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2020 ; 597 1-11 art. 124755.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.colsurfa.2020.124755Vancouver
Henostroza MAB, Melo KJC, Yukuyama MN, Löbenberg R, Bou-Chacra NA. Cationic rifampicin nanoemulsion for the treatment of ocular tuberculosis [Internet]. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2020 ; 597 1-11 art. 124755.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.colsurfa.2020.124755